EUCTR2008-006928-55-GB
进行中（未招募）
不适用
Are early and late cardiovascular risk markers in women with Polycystic Ovary Syndrome increased with concomitant Nonalcoholic Steatohepatitis and can this be modified with Exenatide? - CV risk in PCOS and NASH
Hull and East Yorkshire NHS Trust0 个研究点2009年4月15日
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Hull and East Yorkshire NHS Trust
- 状态
- 进行中（未招募）
- 最后更新
- 14年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Polycystic ovary syndrome (defined by the Rotterdam criteria as 2 out of 3 of:
- •1\.oligo/anovulation
- •2\.clinical or biochemical evidence of hirsuitism, and/or
- •3\.polycystic ovaries on ultrasound.
- •Raised alanine aminotransferase
- •Age 16\-45 years
- •Patients with confirmed NASH
- •Age 16\-45 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
排除标准
- •Type 2 diabetes
- •Hypothyroidism
- •Subjects taking regular prescribed medication
- •Not using a reliable method on contraception (eg barrier/oral contraceptive pill)
- •Patients not allowing disclosure to their GP’s.
- •History of pancreatitis
- •Chronic renal failure (creatinine clearance less than 60 ml/min or plasma creatinine \>150 umol/L)
- •Pregnancy or breastfeeding women
- •Liver function tests \>300% reference range normal (eg ALT\>90 u/mL)
- •Acute conditions with the potential to alter renal function such as:
结局指标
主要结局
未指定
相似试验
已完成
不适用
Do women with polycystic ovary syndrome have increased cardiovascular risk compared to normal controls and could this risk be reduced by liraglutide?ISRCTN48560305Hull and East Yorkshire Hospitals NHS Trust (UK)40
进行中（未招募）
1 期
Are early and late cardiovascular risk markers in women with Polycystic Ovary Syndrome increased with concomitant Nonalcoholic Steatohepatitis and can this be modified with Liraglutide?Polycystic Ovary Syndrome Non-alcoholic SteatohepatitisMedDRA version: 12.0 Level: LLT Classification code 10065161 Term: Polycystic ovarian syndromeMedDRA version: 12.0 Level: LLT Classification code 10053219 Term: Non-alcoholic steatohepatitisEUCTR2009-015927-94-GBHull and East Yorkshire NHS Trust
已完成
不适用
Are early and late cardiovascular risk markers in women with polycystic ovary syndrome (PCOS) increased with concomitant non-alcoholic steatohepatitis (NASH) and can this be modified with exenatide?Polycystic ovary syndrome, non-alcoholic steatohepatitisNutritional, Metabolic, EndocrineOvarian dysfunctionISRCTN81902209Hull and East Yorkshire Hospitals NHS Trust (UK)20
已完成
不适用
Early detection of cardiovascular risk factors after pregnancy complicated by hypertensive disorders or spontaneous preterm birthcardiovascular disease after hypertensive disorders in pregnancy or after spontaneous preterm birth100192801002690810057166NL-OMON45089Vrije Universiteit Medisch Centrum687
已完成
不适用
Biomarkers and cardiovascular risk in disease models of non-alcoholic fatty liver diseaseNL-OMON48654Medisch Universitair Ziekenhuis Maastricht85